title: Benign prostatic hyperplasia: maximizing treatment with alpha blockers.
authors.affiliation: VA Medical Center, Gainesville, FL, USA.
authors.forename: D T
authors.initials: DT
authors.lastname: Lowenthal
authors.forename: M
authors.initials: M
authors.lastname: Flannery
authors.forename: S L
authors.initials: SL
authors.lastname: Mader
authors.forename: R P
authors.initials: RP
authors.lastname: Nelson
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007024:Hypotension, Orthostatic / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000175:diagnosis; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000077409:Tamsulosin; D014563:Urodynamics
chemical_list: D000317:Adrenergic alpha-Antagonists; D013449:Sulfonamides; D017430:Prostate-Specific Antigen; D000077409:Tamsulosin